Streptozotocin (STZ) is the most extensively used chemical agent for experimental type 1 diabetes mellitus (T1DM) that generates reactive oxygen species (ROS) and impairs glucose oxidation, insulin biosynthesis and secretion, and DNA alkylation, thereby causing pancreatic β-cell dysfunction and apoptosis (6–8). This evidence concerns the gene INS and type 1 diabetes mellitus.